TAG:
poct
“November 14, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 16 – November 14, 2005 Issue
Home screening for colon cancer is about to commence on a large scale in the United Kingdom. Beginning in April 2006, two million people between the ages of 60 and 69 will be sent test kits every second year. Consumers will receive Fecal Occult Blood (FOB) test kits. They will collect their own speci…
Lab Tests in Pharmacies, Genzyme, Healthe, Singing River Hospital, VA
By Robert Michel | From the Volume XII No. 15 – October 24, 2005 Issue
IT IS OFTEN SUGGESTED that pharmacies are a logical place to combine laboratory testing with prescription services. Such an arrangement would be consumer-friendly and has the potential to improve patient care while lowering costs. In Great Britain, the National Health Service has launched a pilot pr…
Lab Innovators Point Way At Executive War College
By Robert Michel | From the Volume XII No. 8 – May 30, 2005 Issue
CEO SUMMARY: Now in its tenth year, this Executive War College attracted a record crowd, including laboratory leaders from Europe, Africa, South America, and Asia. The unexpected finding was that, along with the growing acceptance of Lean, Six Sigma and other quality management systems by…
Baylor University Lab Serves ED Needs With STAT Lab
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Throughout the United States, hospital laboratories are working to meet ever-increasing lab testing demands by emergency department physicians. In response, many labs debate the benefits of a point-of-care testing (POCT) solution versus operating a rapid response lab in or ne…
Change Beneath Surface Marks 2004 Lab Stories
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
Baltimore Hospital Lab Problems Put Spotlight On CAP Inspections
CEO SUMMARY: Here’s an exclusive peek into a three-year battle between medical technologists wanting to do the right thing and a laboratory manager—backed by hospital administration—who aggressively stifled well-justified dissent. It is an inside look at one of the most grievous fai…
Side-by-Side Comparison: U.S. Lab Versus British Lab
By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue
CEO SUMMARY: Do clinical laboratories in any of the world’s most developed countries have a performance advantage that makes them “best of breed?” Recently, a laboratory in the United States and a laboratory in the United Kingdom had the opportunity to evaluate their financial, prod…
HCA, Tenet Healthcare, CMS, Abbott Labs, I-Stat, TheraSense
By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue
UNINSURED PATIENT HOSPITAL CHARGES REDUCED AT HCA & TENET For-profit hospital ompanies moved swiftly to announce and publicize new policies for billing uninsured patients. These patients will see charges reduced to levels that are closer to what hospitals accept from HMOs and Medicare/Me…
Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptive—given the technology known to be in d…
New Market Channel For Esoteric Testing
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: It’s a new marketing model for specialty esoteric tests that presents both clinical and financial challenges to hospital and health system laboratories. Niche labs offering esoteric tests are sending sales reps directly to physicians and bypassing pathologists and lab direc…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized